Bacillus MGA3 diaminopimelate decarboxylase gene
CROSS REFERENCE TO RELATED APPLICATION 
     This application is a Continuation-in-Part of U.S. patent application Ser. No. 07/673,263, filed Mar. 20, 1991, now abandoned, which is a Continuation of U.S. patent application Ser. No. 07/351,436, filed May 12, 1989, now abandoned. U.S. patent application Ser. No. 07/673,263 is in turn a Continuation-in-Part of U.S. patent application Ser. No. 07/673,264, filed Mar. 20, 1991, which is a Continuation of U.S. patent application Ser. No. 07/335,691, filed Apr. 10, 1989, now abandoned. 
    
    
     BACKGROUND OF THE INVENTION 
     As shown in FIG. 1, diaminopimelate (DAP) decarboxylase, (EC 4.1.1.20), acts in the last step in the lysine biosynthetic pathway, by catalyzing the decarboxylation of meso-diaminopimelate to lysine. In bacteria, DAP decarboxylase plays a crucial role in balancing two essential metabolites; meso-DAP, a component of cell wall peptidoglycan (and a spore wall component), and the amino acid lysine, used for protein production. DAP decarboxylases isolated from both plants and bacteria have a strict requirement for pyridoxal-phosphate (PLP) as a cofactor. DAP decarboxylase is the only PLP-dependent alpha-decarboxylase known to work on a D-amino acid. 
     Commercially, L-lysine is primarily used as a supplement for animal feeds derived from grains that contain only limited quantities of this amino acid. Poultry, swine, and other livestock are unable to synthesize L-lysine and therefore must have this amino acid supplied as part of their diet. Currently, L-lysine is manufactured by either direct fermentation or enzymatic conversion of DL-α-amino-ε-caprolactam. Fermentation processes using strains of Corynebacterium glutamicum or Brevibacterium lactofermentum have become the major methods for L-lysine production. (O. Tosaka et al., Trends in Biotechnology, 1, 70 (1986)). 
     Recently, F. J. Schendel et al. in J. Appl. Environ. Microbiol., 56, 963 (1990), identified homoserine auxotrophs and S-(2-aminoethyl)-cysteine (AEC) resistant mutants of a thermophilic methylotrophic Bacillus sp. which overproduce significant quantities of L-lysine at 50° C. Such thermophilic methylotrophs may have advantages over other organisms for industrial use, as discussed by Al-Awadhi et al., Biotechnol. Bioeng., 36, 816, 821 (1990). In particular, the methylotrophic Bacillus MGA3 identified by F. J. Schendel et al., cited supra, may have significant advantages over other bacilli for the overproduction of lysine since it does not sporulate at high temperatures even under conditions of nutrient limitation, in contrast to lysine-producing mutants of B. licheniformis that sporulated when grown at temperatures greater than 40° C. (H. Hagino et al., Biotechnol. Lett., 3, 425 (1981)). 
     Since both spore components, diaminopimelate and dipicolinic acid, are derived from the lysine biosynthetic pathway, as shown in FIG. 1, differences in the regulation of this pathway may occur between this thermophilic Bacillus sp. and other mesophilic bacilli. Therefore, a need exists to isolate and characterize the informational macromolecules (DNA and RNA) which function in the biosynthetic pathway to lysine, methionine and threonine in the thermotolerant Bacillus sp. MGA3. A further need exists to isolate and characterize the products, such as the enzymes, that function in these biosynthetic pathways. A further need exists to produce mutant varieties of said informational macromolecules, in order to improve the properties of the enzymes and other polypeptides encoded thereby, or to produce improved strains of thermophilic, methylotrophic bacteria. 
     SUMMARY OF THE INVENTION 
     The present invention provides a DNA sequence in substantially pure form, which corresponds to the structural gene coding for the dimer subunit of lysine-sensitive diaminopimelate (DAP) decarboxylase of the methylotrophic thermotolerant Bacillus sp. MGA3. For brevity, this gene can be referred to as the Bacillus MGA3 lysA gene, and is shown in SEQ. I.D. No. 1. 
     The DNA sequence was identified by cloning the lys A structural gene from a genomic library via complementation of an Escherichia coli auxotrophic mutant lacking DAP decarboxylase (&#34;lysA 22&#34;) as summarized in FIG. 2. The nucleotide sequence of the entire 2.3 Kb PstI fragment has been determined to be as depicted in FIG. 3 and a single open reading frame coding for the about 50 kD enzyme subunit was identified at positions 265-1560 of this fragment. 
     The present invention also provides a substantially pure enzyme corresponding to this form of DAP decarboxylase and a substantially pure polypeptide corresponding to the dimer subunit of DAP decarboxylase. DAP decarboxylase is a dimer (M r  86,000). The N-terminal sequence was found to be identical with those predicted from the gene sequence. The predicted sequence of 432 amino acids (SEQ. I.D. No. 2) shows some sequence homology with the sequence of B. subtilis DAP decarboxylase. 
     Availability of the MGA3 DAP decarboxylase gene, coupled with knowledge of its sequence, permits the production of mutant forms of the present DAP decarboxylase, via mutagenesis of the gene. Mutant forms of the DAP decarboxylase gene may be useful to produce microorganisms such as new strains of bacteria, which overproduce lysine at higher levels, or under even more stringent environmental conditions. Methodologies for the mutagenesis of the DAP decarboxylase gene are known to the art, as discussed in detail in U.S. patent application Ser. No. 07/684,135, filed Apr. 12, 1991 now U.S. Pat. No. 5,243,039. As used herein, the terms meso-diaminopimelate decarboxylase, diaminopimelate decarboxylase and DAP decarboxylase are interchangeable. 
     As used herein, with respect to an enzyme or a subunit thereof, the term &#34;corresponding to DAP decarboxylase&#34; is intended to mean that the enzyme or the subunit referred to exhibits substantial sequence homology to DAP decarboxylase derived from MGA3 (e.g., ≧85-90%) and that the enzyme also exhibits a substantially equivalent profile of bioactivity, e.g., exhibits ≧85-90% of the lysine sensitivity exhibited by DAP decarboxylase from MGA3. 
     As used herein, with respect to a DNA sequence which encodes DAP decarboxylase or a subunit thereof, the term &#34;substantially pure&#34; means that the DNA sequence is free of other DNA sequences that occur naturally in MGA3, e.g., that it has been isolated from MGA3, via the methodologies of recombinant DNA technology, as described herein, or has been prepared by known techniques of organic synthesis. Likewise, as used with respect to a DAP decarboxylase enzyme or a subunit thereof, the term &#34;substantially pure&#34; means that the enzyme is free of the other components of naturally occurring Bacillus, in that it has been isolated from a biological medium or has been prepared by known techniques of organic synthesis or of recombinant DNA technology. 
     All the patents, patent documents and publications cited herein are incorporated by reference herein. 
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS 
     FIG. 1 is a schematic depiction of the lysine biosynthetic pathway used by Bacillus. 
     FIG. 2 schematically depicts the cloning and sequencing of the DAP decarboxylase gene. 
     FIG. 3 depicts the DNA sequence of the MGA3 DAP decarboxylase gene and the amino acid sequence of the DAP decarboxylase dimer subunit. 
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     In bacteria, the subunit molecular weights (MW) of DAP decarboxylases from Escherichia coli, Corynebacterium glutamicum, Pseudomonas aeruginosa and Brevibacterium lactofermentum are all about 50,000, while the native molecular weights differ. A number of gram-positive DAP decarboxylases were each found to have a native MW in the range of 80,000-100,000, indicating a dimeric protein. The same relationship between the DAP decarboxylase subunit and native MGA3 DAP decarboxylase was found in the present investigation. In E. coli, a gram-negative bacteria, DAP decarboxylase has a native MW of 200,000, suggesting a tetrameric MW of 191,000 and a subunit MW of around 50,000. 
     The current model of DAP decarboxylase regulation in E. coli involves two genes, lysA, the gene-encoding DAP decarboxylase and lysR, an activatory regulator of the lysA gene. The two genes are transcribed divergently, separated by 121 base-pairs. P. J. White et al., Biochem. J., 96, 75 (1965), determined that the molecular weight of native E. coli DAP decarboxylase is around 200,000. The lysA gene encodes a 420 amino acid long peptide with a predicted molecular weight of 46,099. This subunit molecular weight indicated a tetrameric native form. The lysR gene encodes a 311 amino acid polypeptide. 
     The synthesis of DAP decarboxylase in E. coli is repressed by lysine through a combined effect of lysine and the lysA product in an autogenous repression. By analysis of both the E. coli and the Pseudomonas aerugenosa lysA genes in an E. coli host containing a chromosomal lysA-lacZ fusion, C. F. Martin et al., FEMS Micro. Lett., 36, 105 (1986) demonstrated that similar intracellular levels of either P. aerugenosa or E. coli DAP decarboxylase activity had very different effects on the expression of the E. coli lysA-lacZ fusion. This indicated that the lysA product itself, not its DAP decarboxylase activity, is involved in the autogenous regulation. Lysine was found to also be an effector in repression, yet this effect was only observed in the presence of sufficient intracellular DAP decarboxylase (measured by its activity). 
     Due to the lack of analogous genetic techniques available for gram-positive bacteria such as MGA3, analysis of the regulation of DAP decarboxylase expression is less well defined than in E. coli. As discussed previously, the lysine biosynthetic pathway in spore-forming bacteria is governed by two goals, the production of lysine and meso-DAP during vegetative growth and that of dipicolinic acid and meso-DAP during spore formation. 
     A. Rosner, in J. Bacteriol., 121, 20 (1975) proposed a sequential-feedback-inhibition mechanism for controlling the cell requirements for meso-DAP during sporulation. By this postulate, lysine is accumulated at a latter stage of growth prior to spoulation. This inhibits DAP decarboxylase which, in turn, increases the intracellular level of meso-DAP necessary to fulfill the increased demand of meso-DAP into cell-wall peptidoglycan. When the biosynthesis of the spore cortex has progressed to a stage where high concentrations of meso-DAP are no longer needed, the meso-DAP concentration increases to a level sufficient to inhibit aspartokinase I, the first enzyme in the pathway, thereby decreasing the carbon flow leading to the synthesis of the aspartate family of amino acids. 
     The MGA3 lysA gene coding for diaminopimelate (DAP) decarboxylase was cloned by complementation of E. coli auxotrophs with a genomic library from MGA3 constructed by cloning into the PstI site of pBR322. A 12.5 Kb fragment complemented the E. coli DAP decarboxylase mutation. Subcloning into pUC vectors of the 12.5 Kb fragment resulted in a 2.3 Kb fragment that coded for DAP decarboxylase activity (FIG. 2). The fragment was sequenced using the Sanger dideoxy method. FIG. 3 shows the nucleotide sequence of the fragment along with the translated DAP-decarboxylase subunit amino acid sequence. A large open reading frame (ORF) was found in the DNA sequence. An ORF coding for a 432 amino acid peptide was found for DAP decarboxylase. The predicted subunit MW of 48,233 for DAP decarboxylase is in good agreement with the B. subtilis enzyme which has a native MW of 100,000, since DAP decarboxylase has been shown to be a dimer in E. coli, Pseudomonas aeruginosa, and Corynebacterium glutamicum. 
     The proposed start site of each protein is shown in bold in FIG. 3, and the proposed ribosome-binding site (RBS) is underlined. While no (consensus) GAGG ribosome-binding site sequence could be found for the ribosome-binding site, the underlined sequence matched the proposed ribosome-binding site in the AK II gene. It also contained possible rho-independent terminators (underlined) at the 5&#39; end of the coding region. 
     The invention will be further described by reference to the following detailed Example. 
     EXAMPLE 1 
     Cloning and Sequencing of DAP Decarboxylase 
     1. Strains, Plasmids and Media 
     The E. coli K12 strain AT2452 thi-1 lysA22 relA1 1-, spoT1 (&#34;lysA22&#34;) was isolated and characterized by A. I. Bukhari et al., J. Bacteriol., 105, 844 (1971). E. coli.DH5αF&#39; F&#39;/endA1 hsdR17 (r K   -  m K   - ) supE44 thi-1 recA-1 gyrA (Nal r ) relA1 D(lacZYA-argF) U169 (j80 lacZDM15) was purchased from Bethesda Research Laboratories (Gaithersburg, Md.). Bacillus MGA3 (ATCC 53907) was isolated at the Gray Freshwater Institute, Minnetonka, Minn., and described by Schendel et al, cited above. 
     E. coli were grown in the following: TB (&#34;terrific broth&#34; containing 1.2% tryptone, 2.4% yeast extract, 0.4% glycerol, 17 mM KH 2  PO 4  and 72 mM K 2  HPO 4 ), SOC (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl 2 , 10 mM Mg 2  SO 4 , 20 mM glucose) (D. Hanahan, DNA Cloning, A Practical Approach, Vol. 1, D. M. Glover, ed., IRL Press, Oxford (1984) at pages 109-135) or M9 minimal media (T. E. Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Lab., N.Y. (1982)) supplemented with 2.5 μg/ml of thiamine, 1.1M glucose, and 50 μg/ml of L-lysine. 
     2. Bacillus MGA3 were grown in minimal salts media (MS) containing the following, in one liter of distilled water: K 2  HPO 4 , 3.8 g; NaH 2  PO 4 .H 2  O, 2.8 g; (NH 4 ) 2  SO 2 , 3.6 g; MgSO 4 .7H 2  O, 0.5 g; FeSO 4 .7H 2  O, 2 mg; CuSO 4 .5H 2  O, 40 μg; H 3  BO 3 , 30 μg; MnSO 4 .H 2  O, 200 μg; ZnSO 4 .7H 2  O, 200 μg; Na 2  MoO 4 .2H 2  O, 47 μg; CaCl 2 .H 2  O, 5.3 mg; CaCl 2 .6H 2  O, 40 μg. The pH was adjusted to 7.4 prior to autoclaving. The minimal vitamin (MV) medium was the MS medium supplemented with biotin, 50 μg/liter, and vitamin B 12 , 1 μg/liter. Yeast extract (MY) medium was MV medium containing 0.5 g/liter yeast extract. Both MV and MY media contained 0.5% (vol/vol) methanol. MV or MY plating media contained 1.5% bacto-agar and the following modifications: (NH 4 ) 2  SO 2  was reduced to 1.3 g/liter, K 2  HPO 4  to 0.4 g/liter and NaH 2  PO 4 .H 2  O was omitted. 
     The E. coli plasmid pUC18 (ampicillin R ) was a gift from Dr. P. B. Hackett and the plasmid pUC19 (chloramphenicol R ) was a gift of Dr. J. Fuchs. 
     3. Biochemicals 
     Restriction endonucleases, T4 DNA ligase, Klenow fragment of DNA polymerase 1, and Bacterial Alkaline Phosphatase were purchased from Bethesda Research Laboratories (Gaithersburg, Md.). Sequenase, dideoxynucleotide mixes, and Universal (-20) and -40 forward-sequencing primer were purchased from U.S. Biochemical Corp. (Cleveland, Ohio). The T7 reverse sequencing primer, exonuclease 111/S1 nuclease &#34;Erase-a-Base&#34; nested deletion kit was purchased from Promega Corp. (Madison, Wis.). α 32  P-dATP (1000 Ci/mmol) was purchased from Amersham Corp. (Arlington Heights, Ill.). α 32  P-dCTP (3000 Ci/mmol) and γ 32  P-dATP (3000 Ci/mmol) were purchased from Dupont-NEN (Boston, Mass.). 
     1,7- 14  C-diaminopimelate (mixed isomers, 29 mCi/mmol) was purchased from ICN Biochemicals (Irvine, Calif.). Hyamine hydroxide, β-mercaptoethanol, L-lysine, and other basic reagents were purchased from Sigma Chemical Co. (St. Louis, Mo.). 
     4. Plasmid Mini-Preps 
     Plasmid DNA from E. coli was isolated by the method of H. C. Birnham et al., Nucl. Acids Res., 7, 1513 (1979), with the following modifications. One ml of cells from an overnight TB culture was pelleted in a 1.5 ml microfuge tube and resuspended in 100 μl of solution A (50 mM glucose, 25 mM Tris-HCl, pH 8.0, 10 mM EDTA). To this mixture 200 μl of solution B (0.2N NaOH, 1% SDS) was added, followed by inversion several times to ensure mixing. 175 μl of solution C (3M sodium acetate, pH 4.8) was then added, the eppendorf tube mixed by inversion, and placed at -20° C. for 20 minutes. The solution was pelleted for 5 minutes in an eppendorf centrifuge and the supernatant saved. The DNA in the supernatant solution was then precipitated with 400 μl of isopropanol, resuspended in 200 μl of 03M NaCl and precipitated again with 400 μl of 95% ethanol. The pellet was then air-dried and resuspended in 50 μl TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). For a typical restriction analysis, 5 μl of this solution was used with 1 μl of 10 μg/ml RNAse, and the restriction enzyme of choice. 
     5. Plasmid Midi-Preps 
     Purification of plasmid for double-stranded dideoxy-chain termination sequencing was performed according to the procedure of P. Kreig et al. (Promega Catalog, Madison, Wis. (1986)). Fifty ml of overnight culture was pelleted in a 30 ml corex tube at 5000 rpm in a Beckmann JA10 rotor. The pellet was resuspended in 6 ml of 25 mM Tris-HCl, pH 8.0, 10 mM EDTA, 15% sucrose, and 2 mg/ml lysozyme (added fresh) and incubated on ice for 20 minutes. To this solution was added 20 ml of 0.2N NaOH, 1% SDS. The mixture was inverted gently and incubated on ice for 10 minutes. 7.5 ml of 3M sodium acetate, pH 4.8, was added and the solution again mixed gently by inversion. The mixture was centrifuged in a Beckmann JA10 rotor at 15000 rpm for 15 minutes. The supernate was removed and the nucleic acids precipitated with 0.6 volume of isopropanol. The resulting pellet was then resuspended in 5 ml of TE containing 50 μg/ml RNAse. After incubation at 37° C. for 20 minutes, the solution was extracted twice with 5 ml of phenol saturated with TE, and once with 5 ml of phenol:chloroform (1:1). The plasmid DNA was then pelleted with 2.5 volumes of 95% ethanol. The resulting pellet was resuspended in 1.6 ml of H 2  O to which 0.4 ml of 4M NaCl was added and the solution mixed. Two ml of 13% polyethylene-glycol (MW-8000) was then added and the mixture incubated on ice for 1 hour. The mixture was then centrifuged at 10,000 rmp (Beckmann JA20) and the pellet washed with 70% and then 95% ethanol. Finally the pellet was dissolved in 200 μl of TE and the plasmid concentration determined by optical density at A260. 
     6. Preparation of Bacillus MGA3 Chromosomal DNA 
     Chromosomal DNA was isolated by the procedure of R. E. Yasbin et., J. Bacteriol., 121, 296 (1975), with the following modifications. Bacterial cells were incubated overnight in 100 ml of MY media (Bacillus MGA3) at 50° C. and centrifuged 4000×g in a Beckman JA20 rotor for 10 min. The cell pellet was resuspended in 0.05× of the starting volume in STET buffer (5% Sucrose, 8% Triton-X 100, 50 mM EDTA, 50 mM Tris-Cl, pH 8.0) plus lysozyme (100 μl/ml final concentration; Sigma) for 1 hour at 37° C. Proteinase K (40 μl/ml final concentration) and RNase A (20 μg/ml final conc.) were added and the preparation allowed to incubate a further hour at 37° C. Sodium dodecyl sulfate (SDS) and Sarkosyl (0.1 ml from a stock solution containing 10% SDS and 8% Sarkosyl per 5 ml DNA preparation) were added and gently mixed at 50° C. until all membrane material was dissolved (around 20 minutes). The preparation was then extracted twice with TE saturated phenol and once with chloroform (24:1, chloroform: isoamyl alcohol). DNA was then isolated by layering onto the preparation 2 volumes of ice-cold 95% ethanol and spooling the DNA around a glass rod. The DNA remaining on the glass rod was washed twice with 95% ethanol, air dried 10 minutes at room temperature and redissolved in TE (10 mM Tris-Cl pH 8.0, 1 mM EDTA). 
     7. DNA Cloning Experiments 
     All restriction enzymes, T4 ligase, Klenow fragment, and Bacterial Alkaline Phosphatase, were used as recommended by the suppliers. DNA fragments were analyzed by horizontal electrophoresis in agarose gels with TAE buffer. Lamda DNA (BRL) cut with Hind 111 and Bst E 11 was used as a molecular weight standard as well as a concentration reference. DNA fragments were isolated from low melting point agarose (BioRad) by the method of Langridge et al., Anal. Biochem., 103, 264 (1980). 
     8. Transformation of E. coli, CaCl 2  -RbCl Transformation 
     Transformation of E. coli was performed essentially as described in Hanahan, cited above. E. coli cells were grown in 500 ml of SOC media in a 21 shake flask to a cell density of 4-7×10 7  CFU/ml (O.D. of 1.0). The cells were centrifuged at 4000×g for 10 minutes and resuspended in 167 ml (1/3 volume) of sterile RF1 (100 mM RbCl, 50 mM MgCl 2 .4H 2  O, 30 mM potassium acetate, 10 mM CaCl 2 .2H 2  O, 15% glycerol--adjusting pH to 5.8 with 0.2M acetate acid). The cells were then incubated on ice for 20 minutes and centrifuged at 4000×g for 10 minutes. This final pellet resuspended in 42 ml (1/12 volume) sterile RF2 (10 mM, pH 6.8, 10 mM RbCl, 75 mM CaCl 2  2H 2  O, 15% glycerol) and incubated on ice for 15 minutes. The competent cells were distributed into 200 μl aliquots and quick frozen in a dry ice/ethanol bath and placed at -70° C. 
     For a simple transformation a tube(s) was removed and allowed to thaw at room temperature. The DNA was added in a volume of less than 20 μl, mixed by swirling the tube, and incubated on ice for 30 minutes. The cells were then heat shocked at 42° C. for one minute and immediately placed on ice. 800 μl of SOC medium was then added and the cells incubated at 37° C. for 30 minutes. Finally, the cells were plated on the appropriate media for selection. 
     9. Transformation of E. coli, Electroporation 
     The E. coli cells were grown in 500 ml of TB to an optical density of (OD 600nm ) of 1.0. The cells were harvested by centrifugation 4000×g for 15 minutes. The cell pellet was then washed twice in 500 ml of sterile H 2  O and resuspended in 10 ml of cold 10% glycerol. The cells were then distributed in 50 μl aliquots, quick frozen in a dry ice/ethanol bath and stored at -70° C. 
     Transformation was performed by mixing 1 μl of DNA solution (10 ng-10 ug/μl) with the 50 μl electrocompetent cells, placing the solution inside an electrode (BTX), and pulsing with 17 Kv/cm for 5 ms. The transformed cells were then immediately placed in 300 μl of SOC medium and incubated at 37° C. for 30 minutes. Finally the cells were plated on the appropriate media for selection. 
     10. DNA Sequencing 
     The pUC18am-lys2.3 Sma1-Sst1 fragment was sequenced by the dideoxynucleotide chain termination method of F. Sanger et al. (PNAS USA, 71, 5463 (1977)), using M13 universal primers (-20 and -40) (New England BioLab) in the forward direction and the T7 reverse sequencing primer (Promega) for the reverse direction. Gaps in the complete sequence were filled in by synthezing primers on an Applied Biosystems primer system according to the manufacturer&#39;s recommendations. Sequencing reactions were separated using buffer gradient urea/acrylamide gels as described by M. D. Biggin et al. (PNAS USA, 80, 3963 (1983)). Sequence data was analyzed using Intellegenetics software. 
     11. Preparation of Cell Extracts 
     E. coli lysA22 cells were grown to an OD 600nm  of between 0.7 and 1.0 in 100 ml of minimal M9 media supplemente with 50 μl/ml L-lysine (for those plasmids not encoding a DAP decarboxylase activity) and appropriate antibiotic. The cells were washed in 10 ml of DAP decarboxylase enzymatic assay buffer (see below), collected and resuspended in 3 ml of the same buffer, and sonicated on ice for 30 seconds at 95% using a Biotip sonicator. The cell debris was then centrifuged at 16000×g for 20 minutes and the cell supernatant removed and assayed for protein concentration and DAP decarboxylase activity 
     12. Measurement of DAP Decarboxylase Activity 
     DAP decarboxylase assays were performed on column fractions or crude E. coli cell extracts as described by J. G. Kelland et al., Biochemistry, 24, 3263 (1985), with the following modifications. The assay mixtures contained 50 mM potassium phosphate and 50 mM MOPS buffers at pH 7.5, 1 mM EDTA, 1 mM β-mercaptoethanol, 0.2 μl pyridoxal-5&#39;-phosphate, 10 nCi of [1,7- 14  C] diaminopimelate (mixed isomers) and enzyme to a final volume of 1 ml. The reaction was performed in scintillation vials with caps containing a 1.5 cm×1.5 cm piece of Whatmann 3MM filter paper saturated with 20 μl of 1M hyamine hydroxide as a  14  CO 2  trapping agent. The reaction was initiated by addition of enzyme and the assay mixture incubated at 50° C. for 5 minutes with continual shaking. The reaction was quenched by addition of 200 μl of 10% TCA and the vial shaken in additional 15 minutes to ensure complete  14  CO 2  evolution. The filter paper was then removed and counted in 10 ml of EcoScint scintillation cocktail on a Beckman LS7000 scintillation counter. One unit of DAP decarboxylase activity is defined as the amount of enzyme which liberates 1 umol of CO 2  per minute. Protein concentrations were determined by the absorbance at 280  nm or by a modified Lowry method (J. Biol. Chem., 193, 265 (1951)). 
     13. Results and Discussion 
     A. Subcloning of an E. coli Strain AT2452 (lysA22) 
     The plasmid PDM1 shown in FIG. 2 carries a 12.5 Kb Pst1 fragment isolated from Bacillus MGA3 chromosomal DNA in the Pst1 site on the plasmid pBR322. This fragment and restriction fragments thereof, were subcloned into pUC19cm vectors and used to complement E. coli strain AT2452 (lysA22). This allowed the localization of the Bacillus MGA3 lysA-complementing gene within a 2.3 Kb Sma1-Sst1 fragment. Further restriction analysis indicated neither Ava11-Sst1 fragment nor the Sma1-Ava11 was able to complement the E. coli lysA22 auxotroph indicating the Bacillus MGA3 meso-DAP decarboxylase encoding fragment lies completely within the Sma1-Sst1 fragment. 
     B. Nucleotide Sequence of the lysA-complementing Gene 
     The nucleotide sequence of the 2.3 Kb Sma1-Sst1 fragment was determined by the method of F. Sanger et al., PNAS USA, 71, 5463 (1977). Deletion subclones of the Sma1-Sst1 fragment were created utilizing the Erase-A-Base kit (Promega Corp.) as recommended by the manufacturer. Subclones were sequenced using &#34;universal&#34; -20 and -40 primers and the T7 reverse sequencing primer with gaps in the sequence filled by primers synthesized at BPTI. The strategy allowed complete determination of both strands. As shown in FIG. 3, there is one large open reading frame with an initiating ATG codon and a putative ribosome-binding site (RBS) GGGA six bases upstream of the initiating methionine codon. The open reading frame encodes a 437 amino acid peptide corresponding to a 48,223 kD protein. This is the DAP decarboxylase dimer subunit. 
     One hundred and seventy-four basepairs upstream from the translation start site is a putative promoter structure, -10/-35 region closely matching the promoter identified in the aspartokinase II gene. Immediately downstream of the Bacillus MGA3 meso-DAP decarboxylase open reading frame is a region of dyad symmetry. followed by a string of pyrimidine bases indicative of a ρ-independent termination site in other bacteria. 
     Analysis of the Bacillus MGA3 lysA 3&#39; flanking sequences reveal another open reading frame 387 basepairs downstream of the lysA stop codon. The open reading frame encodes a 102 amino acid peptide and possesses a typical ribosome-binding site concensus (&#34;GAGG&#34;) immediately upstream of the initiating methionine codon. The identity of this putative open reading frame has yet to be determined. 
     C. DAP Decarboxylase Purification 
     For all of the following physical and kinetic analysis, the Bacillus MGA3 meso-DAP decarboxylase was purified from an E. coli lysA22 auxotrophic mutant containing the pDM5 plasmid. The purification occurred as per Y. Asada et al., Biol. Chem., 45, 1513 (1981), with the following modifications. All steps of the purification occurred at 4° C. E. coli AT2452 thi 1 lysA22 relA11-spoT1:pDM1 containing the recombinant Bacillus MGA3 lysA gene was grown in a 30 liter New Brunswick fermentor with base addition using TB media as described in materials and methods. 
     For a typical purification, 65 grams of wet cell paste was resuspended in 200 ml of 4° C. purification buffer #1 (50 mM KPO 4 , pH 7.5, 1 mM EDTA, 20 μM PLP, 0.01% 2-mercaptoethanol) and disrupted by passage twice through a French Press. The supernatant obtained by centrifugation for 1 hour at 20,000 rpm in a Beckmann JA20 rotor at 4° C., was fractionated with ammonium sulfate (25% to 40% saturation). The resulting fraction was desalted by passage through a Sephadex G-25 column (27 cm×2.5 cm) and the protein peak diluted two-fold with purification buffer #1 before application to a DEAE-agarose column equilibrated with the same buffer. 
     After washing the column, the enzyme was eluted with a potassium chloride gradient (0 to 300 mM KCl) in purification buffer #1. Active fractions, eluting around 200 mM KCl, were pooled and dialyzed against purification buffer #2 (10 mM KPO 4 , pH 6.5, 1 mM EDTA, 20 μM PLP, 0.01% 2-mercaptoethanol). The enzyme pool was then applied to a hydroxyapatite column (20 cm×1 cm) previously equilibrated in purification buffer #2 and further washed in purification buffer #2. The enzyme was eluted with a potassium phosphate gradient (10 mM to 300 mM KPO 4 ) in purification buffer #2 with the active fractions centering around 60 mM KPO 4 . The enzyme was then pooled and dialyzed against purification buffer #1 prior to: 1) application to Sephacryl S-300 sizing column, 2) kinetic analysis, 3) further purification on a FPLC mono-Q column prior to N-terminal sequencing. 
     D. DAP Decarboxylase Enzyme--Physical Characterizations 
     1. Molecular Weight Analysis 
     As determined by SDS-PAGE analysis, the subunit molecular weight of DAP decarboxylase is around 50,000. This correlates well with the predicted molecular weight of the Bacillus MGA3 DAP decarboxylase dimer subunit sequence (48,223 MW). The native molecular weight is 86,000 as determined by the Sephacryl S-300 gel filtration method of P. Andews, Biochem. J., 91, 222 (1965). 
     2. N-Terminal Sequencing 
     Prior to N-terminal sequencing, hydroxyapatite fractions were pooled and concentrated via ultrafiltration and applied to a FPLC mono-Q column previously equilibrated with purification buffer #1. Using a potassium chloride gradient (1 to 1M KCl) in purification buffer #1, DAP decarboxylase-active fractions were eluted at around 100 mM KCl. These fractions were pooled and protein was TCA-precipitated prior to SDS-polyacrylamide gel electrophoresis and subsequent transfer to a ProBlott membrane (BioRad). Electrophoretic transfer of protein of the ProBlott polyvinylidene diflouride (PVDF) membrane was performed as described by P. Matsudaira, J. Biol. Chem., 262, 10035 (1987). The DAP decarboxylase protein bands, identified by relative mobility compared to previous SDS-PAGE gels, were excised and stored in glass vials. N-terminal sequence analysis was performed at the University of Minnesota, Microchemical facility. 
     The N-terminal sequence determined, Met-Tyr-Phe-X-X-Thr-X-Lys-Val, matches the predicted start site as exactly indicated from the DNA sequence shown in FIG. 3. 
     3. DAP Decarboxylase Enzyme--Kinetic Characterizations 
     For Bacillus MGA3 meso-DAP decarboxylase, the concentration of diaminopimelate necessary for half-maximal activity was determined to be 0.80 mM. L-lysine behaved as a competitive inhibitor (Ki=0.93 mM) with respect to diaminopimelate. Other amino acids alone or in combination with lysine did not inhibit the enzyme (Table 1). 
     
                       TABLE 1.                                                    
______________________________________                                    
Enzyme Inhibition at 37° C.                                        
Amino Acid  % Inhibition                                                  
Addition (5 mM)                                                           
            DAP Decarboxylase                                             
                           Aspartokinase II                               
______________________________________                                    
none         0             0                                              
lys         85             96                                             
thr         10             0                                              
met         19             8                                              
ile         16             0                                              
lys (0.5 mM)                                                              
            41             76                                             
lys (0.5 mM),                                                             
            37             77                                             
thr (5 mM)                                                                
______________________________________                                    
 
    
     
         __________________________________________________________________________
SEQUENCE LISTING                                                          
(1) GENERAL INFORMATION:                                                  
(iii) NUMBER OF SEQUENCES: 2                                              
(2) INFORMATION FOR SEQ ID NO:1:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 2368 base pairs                                               
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: single                                                  
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: DNA (genomic)                                         
(vii) IMMEDIATE SOURCE:                                                   
( B) CLONE: DAP Decarboxylase Gene                                        
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 265..1560                                                   
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                   
CGGGTCAAAAATACGCCCAAGCATCATTCATACAAAAAATCGATACCGCCAACCGACATA60            
AGAAAAGCAGAAGCATTATGCAACTTGAATCAATTGCGAATTTTCAAATC TTATGGTAAG120          
TTTGTTTTTATTAAAGAATCCATTAAAGGGCAGAAATCAATACCTACTTGAAAGATTCTA180           
TTCATTTGTTTATATTCAAAATAATTCATTTTTAATAAATATTCGGGATCGACATATTGA240           
GTGATAAGGGGAATGGGAACAGAAAT GTATTTTCATGGCACAACAAAGGTA291                   
MetTyrPheHisGlyThrThrLysVal                                               
15                                                                        
AATGAAAAGGGACATTTAGAAATCGGCGGAGT GGATACGATCGAACTT339                      
AsnGluLysGlyHisLeuGluIleGlyGlyValAspThrIleGluLeu                          
10152025                                                                  
GCACAAAAGTATGGCACGCCTCTATATG TATACGACGTTGCTTTAATT387                      
AlaGlnLysTyrGlyThrProLeuTyrValTyrAspValAlaLeuIle                          
303540                                                                    
CGCGAGCGGGCTAGAGGGTTTAAAAAT ACGTTTGATGAGCTTGGTATT435                      
ArgGluArgAlaArgGlyPheLysAsnThrPheAspGluLeuGlyIle                          
455055                                                                    
AAAGCTCAAGTTGCATATGCAAGCAAAGCA TTTTCTACAGTAGCAATG483                      
LysAlaGlnValAlaTyrAlaSerLysAlaPheSerThrValAlaMet                          
606570                                                                    
ATTCAGCTTGCAGAAGAGGAAGGCTTGTCACTGGA TGTTGTATCAGGC531                      
IleGlnLeuAlaGluGluGluGlyLeuSerLeuAspValValSerGly                          
758085                                                                    
GGAGAGCTTTATACAGCTTTGGTCGCAGGTTTCCCTGTTCATA AAATC579                      
GlyGluLeuTyrThrAlaLeuValAlaGlyPheProValHisLysIle                          
9095100105                                                                
CATTTTCATGGTAATAATAAAAGCAGAGCCGAACTGGAA ATGGCATTG627                      
HisPheHisGlyAsnAsnLysSerArgAlaGluLeuGluMetAlaLeu                          
110115120                                                                 
GAGCACCAAATAGGCTGCATTGTTGTAGATAATTTTCAT GAACTTGAT675                      
GluHisGlnIleGlyCysIleValValAspAsnPheHisGluLeuAsp                          
125130135                                                                 
CTTATTGATTCCATATGTTCCGAAAAGAATGTAAAAACAAA TATTCTT723                      
LeuIleAspSerIleCysSerGluLysAsnValLysThrAsnIleLeu                          
140145150                                                                 
TTGAGAGTAACTCCAGGAATTGAGGCTCATACGCATGACTATATTT TA771                      
LeuArgValThrProGlyIleGluAlaHisThrHisAspTyrIleLeu                          
155160165                                                                 
ACGGGGCAGGAAGACTCTAAGTTTGGGTTTGACCTTCAAAACGGCCAG819                       
ThrGlyGlnGluAspSerLysPheGlyPheAspLeuGlnAsnGlyGln                          
170175180185                                                              
GCTGAAAAAGCACTTCAAATTGCGTTAAATTCAAACTTTGTTGAAGTT 867                      
AlaGluLysAlaLeuGlnIleAlaLeuAsnSerAsnPheValGluVal                          
190195200                                                                 
CTCGGGGTTCACTGCCATATTGGTTCACAAATTTTTGATACTACCGGA 915                      
LeuGlyValHisCysHisIleGlySerGlnIlePheAspThrThrGly                          
205210215                                                                 
TTTGTTCTAGCAGCAAGAAAAATCTTTGAAAAATTAAAGGAATGGAAA 963                      
PheValLeuAlaAlaArgLysIlePheGluLysLeuLysGluTrpLys                          
220225230                                                                 
GATAGGCTGTCATACGAGCCAAAAGTATTAAATCTTGGAGGCGGATTC1011                      
As pArgLeuSerTyrGluProLysValLeuAsnLeuGlyGlyGlyPhe                         
235240245                                                                 
GGAATTCGTTATACAGAGGAAGATGATCCTATTCCAGCATCTCAATAT1059                      
GlyIleArgT yrThrGluGluAspAspProIleProAlaSerGlnTyr                         
250255260265                                                              
GTGAAAGAAATTATTAACGAAGTGAAAAAACAAGTATCCGCTTATTCC1107                      
ValLys GluIleIleAsnGluValLysLysGlnValSerAlaTyrSer                         
270275280                                                                 
ATGAAAATGCCTGAAATTTGGATTGAACCTGGGCGTTCTCTTGTTGGT1155                      
MetLys MetProGluIleTrpIleGluProGlyArgSerLeuValGly                         
285290295                                                                 
GATGCTGGAACAACATTATATCAGATCGGTTCTAGGAAAGATGTCCCA1203                      
AspAlaGl yThrThrLeuTyrGlnIleGlySerArgLysAspValPro                         
300305310                                                                 
AACGTGAGGCATTATGTGGCTGTAGACGGAGGTATGAGTGACAATATC1251                      
AsnValArgHisT yrValAlaValAspGlyGlyMetSerAspAsnIle                         
315320325                                                                 
CGCCCCGCTTTGTACAATGCTAAGTATGAAGCTGTATTGGCAAATAAA1299                      
ArgProAlaLeuTyrAsnAla LysTyrGluAlaValLeuAlaAsnLys                         
330335340345                                                              
CCACTTGCGAAAGCGGATGAAACAGTTTCAATTGCAGGCAAGTGCTGT1347                      
ProLeuAlaLysAlaAsp GluThrValSerIleAlaGlyLysCysCys                         
350355360                                                                 
GAATCAGGAGATATGCTTATATGGGATTTGCCTCTTCCTAAAGCGGAC1395                      
GluSerGlyAspMetLe uIleTrpAspLeuProLeuProLysAlaAsp                         
365370375                                                                 
AGTGATGATATACTTGCTGTCTTTTGTACCGGAGCATATGGTTATTCA1443                      
SerAspAspIleLeuAlaV alPheCysThrGlyAlaTyrGlyTyrSer                         
380385390                                                                 
ATGGCAAATAATTATAACCGGATTCCAAGGCCGGCCGTGGTATTTGTT1491                      
MetAlaAsnAsnTyrAsnArgIle ProArgProAlaValValPheVal                         
395400405                                                                 
GAGAATGGGGAATCAATGCTTGTAGTGAAACGGAAACATATGAGGACC1539                      
GluAsnGlyGluSerMetLeuValValLysArg LysHisMetArgThr                         
410415420425                                                              
TCGTCCGCAATGATCTGCCTTTAAAAGAAAGAGTAAGATACTAAGCTGCCG1590                   
SerSerAlaMetIleCysLeu                                                     
 430                                                                      
GTTCTCGGCAGCTTAGTTACTAGAAGATGGATTAAAAATGCATTTTAGTGTAGAATTAGG1650          
AACAGCTTATTGTTTATATTATAGGCTGGGAGGATCTGATTCATTTATGAAAAAAGAAAA1710          
TTGGTTGGTGTTTTCTTTTATTCTTGTCATGTCG TTGCTATGGGGATGTTTCTATTGGTT1770         
CTTTATTGCGCCTATACAATGATATAAAATGACCTTGACAAGAAATTGAAGAATTGCCAT1830          
CATTTTTATATGATAAGGTCAATTACTAGACACGCCATAACACATTTCAACATATACTAA1890          
ATGTCAAAGTT CATAAATTGGTGAACAAAAAAGTTCGAATTCATTAATGAGGGATCAGTA1950         
TGTTAATACGTTATAAGAAAGCATTTGAAAAAATAGCAATGGGACTTTTATCCTTTATGC2010          
CAAATGAGAAGGATTTGAAGAAACTTCAGCAAACGATGAAGCAGTATGAAACCGAAG AAG2070         
ACCGACAGTTGTTTCTGTGGAAGGAAGAGGAAGATATTATCGGCCTTATAGGTGTACTTG2130          
TTGTTAATGAATACGAAGTCGAAATACATCATATATCTGTTAACCCTTCACATCGTCATC2190          
AAGGTATAGGCAAGAGTATGGTAAAGGCATTAAG AGATATTTATCCTGATAAAGAGCTGA2250         
TACCAAATGAAAATACAGCGGCTTTCATAGAAAAATGTGAGATTTGTCATGGCAGTGAAT2310          
AATGATTATTCGCTGCCTTTTTTCTTTCGATTGATCATTGCAATTTCCGTTCTTTATG2368            
(2) INFORMATION FOR SEQ ID NO:2:                                          
 (i) SEQUENCE CHARACTERISTICS:                                            
(A) LENGTH: 432 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(vii) IMMEDIATE SOURCE:                                                   
(B) CLONE: Decarboxylase                                                  
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                   
MetTyrPheHisGlyThrThrLysValAsnGluLysGlyHisLeuGlu                          
 151015                                                                   
IleGlyGlyValAspThrIleGluLeuAlaGlnLysTyrGlyThrPro                          
202530                                                                    
 LeuTyrValTyrAspValAlaLeuIleArgGluArgAlaArgGlyPhe                         
354045                                                                    
LysAsnThrPheAspGluLeuGlyIleLysAlaGlnValAlaTyrAla                          
 505560                                                                   
SerLysAlaPheSerThrValAlaMetIleGlnLeuAlaGluGluGlu                          
65707580                                                                  
GlyLeu SerLeuAspValValSerGlyGlyGluLeuTyrThrAlaLeu                         
859095                                                                    
ValAlaGlyPheProValHisLysIleHisPheHisGlyAsnAsnLys                          
 100105110                                                                
SerArgAlaGluLeuGluMetAlaLeuGluHisGlnIleGlyCysIle                          
115120125                                                                 
ValValAs pAsnPheHisGluLeuAspLeuIleAspSerIleCysSer                         
130135140                                                                 
GluLysAsnValLysThrAsnIleLeuLeuArgValThrProGlyIle                          
145 150155160                                                             
GluAlaHisThrHisAspTyrIleLeuThrGlyGlnGluAspSerLys                          
165170175                                                                 
PheGly PheAspLeuGlnAsnGlyGlnAlaGluLysAlaLeuGlnIle                         
180185190                                                                 
AlaLeuAsnSerAsnPheValGluValLeuGlyValHisCysHisIle                          
 195200205                                                                
GlySerGlnIlePheAspThrThrGlyPheValLeuAlaAlaArgLys                          
210215220                                                                 
IlePheGluLysLeu LysGluTrpLysAspArgLeuSerTyrGluPro                         
225230235240                                                              
LysValLeuAsnLeuGlyGlyGlyPheGlyIleArgTyrThrGluGlu                          
 245250255                                                                
AspAspProIleProAlaSerGlnTyrValLysGluIleIleAsnGlu                          
260265270                                                                 
ValLysL ysGlnValSerAlaTyrSerMetLysMetProGluIleTrp                         
275280285                                                                 
IleGluProGlyArgSerLeuValGlyAspAlaGlyThrThrLeuTyr                          
290 295300                                                                
GlnIleGlySerArgLysAspValProAsnValArgHisTyrValAla                          
305310315320                                                              
ValAspGlyGl yMetSerAspAsnIleArgProAlaLeuTyrAsnAla                         
325330335                                                                 
LysTyrGluAlaValLeuAlaAsnLysProLeuAlaLysAlaAspGlu                          
 340345350                                                                
ThrValSerIleAlaGlyLysCysCysGluSerGlyAspMetLeuIle                          
355360365                                                                 
TrpAspLeuPro LeuProLysAlaAspSerAspAspIleLeuAlaVal                         
370375380                                                                 
PheCysThrGlyAlaTyrGlyTyrSerMetAlaAsnAsnTyrAsnArg                          
385 390395400                                                             
IleProArgProAlaValValPheValGluAsnGlyGluSerMetLeu                          
405410415                                                                 
ValValLys ArgLysHisMetArgThrSerSerAlaMetIleCysLeu                         
420425430